Investigational oral antibiotic, zoliflodacin, cured most cases of uncomplicated gonorrhea in Phase 2 trials
by Press Release from Outbreak News Today on (#42FP8)
An investigational oral antibiotic called zoliflodacin was well-tolerated and successfully cured most cases of uncomplicated gonorrhea when tested in a Phase 2 multicenter clinical trial, according to findings published today in the New England Journal of Medicine. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, sponsored the clinical ["]
The post Investigational oral antibiotic, zoliflodacin, cured most cases of uncomplicated gonorrhea in Phase 2 trials appeared first on Outbreak News Today.